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Paradise certainly comes in many different flavors in the mind
of each individual. Well, many of these flavors were recently
combined at a beach resort south of the city of Rio de Janeiro,
Brazil, where the first meeting on ‘Signaling in Cell Death,
Cancer and the Immune System’ was held, creating an
incredible atmosphere of intellectuality, joy and friendship.
There, first-class scientists shared their most recent work and
insights with an enthusiastic group of young scientists and
graduate students. Around 200 people gathered at the
conference and poster section rooms, the overflowing
restaurant or the surroundings of a complex of swimming
pools and bars. Seasoning the intense scientific discussions
were the spectacular view of the ocean, fine sand beach,
coconut water and caipirinhas!
The aim of this meeting was to put together a multi-
disciplinary scientific program with focus on signaling trans-
duction that could gather scientists from the fields of cell
death, tumor biology and immunology. As you will be able to
appreciate from the next paragraphs, the results were
outstanding.
The meeting started with a symposium that highlighted
novel mechanisms operating in cell death, cancer and innate
immunity. Seamus Martin (Trinity College Dublin, Ireland)
revealed a novel p53-independent, ERK-regulated pathway
responsible for the induction of a proapoptotic member of the
Bcl-2 family, namely NOXA, important for the chemother-
apeutic properties of platinum compounds. Scott Lowe
(Howard Hughes Medical Institute and Cold Spring Harbor
Laboratory, USA) put forward powerful global genetic
approaches based on ex vivo manipulation of stem cells, in
particular with libraries of shRNA, followed by transplantation
of these cells to syngeneic recipient mice. As a consequence,
his team can now create mosaic mouse models to study the
role of tumor suppression genes and the cell death machinery
in tumor maintenance or regression. Luke O’Neill (Trinity
College Dublin, Ireland) showed that the small G protein
Rab39a seems to contain a putative caspase-1 cleavage site
at D148. Because the removal of Rab39 from phagolyso-
somes is essential for its acidification and the knocking down
of Rab39a inhibits IL-1b secretion but not TNF-a, O’Neill
proposed that Rab39a functions as a traffic adapter linking
caspase-1 to IL-1b secretion.
Taking advantage of his innovative mind, Ruslan Medzhitov
(Howard Hughes Medical Institute and Yale University School
of Medicine, USA) presented the Keynote Lecture offering us
his personal view about the formation and maintenance of
tissues in multicellular organisms. Anchored in elegant results
from his group as well as from others, he called our attention to
the existence of a certain level of control of life and death in
tissues based on the relative fitness of cells. Interestingly, less
fitted or ‘loser’ cells are only eliminated in the presence of
‘winners’, suggesting the existence of a mechanism aiming to
enhance body fitness, but that still preserves architecture and
function of the less robust tissue. Passive competition takes
place predominantly (or maybe only) during restrictive
situations (stress, or limitations in space, growth factors,
nutrients, etc.) and seems to be dependent on
cell-intrinsic differences to react to the restrictive environment.
A major player identified by Medzhitov and colleagues is p53,
expression of which is higher in ‘loser’ than ‘winner’ cells.
Active competition, however, is likely to be cell extrinsic and
may occur at the steady/homeostatic state of a given tissue.
‘Winners’, in this case, may actively suppress or even kill the
‘losers’, and the ‘losers’ may even promote the growth of the
‘winners’. Importantly, in any of this situations, a complex set
of communication signals appears to control the ‘social
behavior of cells’, aspiring for a healthier organism. Also, at
least at the cellular level, the Darwinian ‘survival of the fittest’
is based not only in competition, but also in cooperation and
sacrifice.
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Regulation of Signal Transduction and Gene Expression
Emer S Ferro (Instituto de Cieˆncias Biome´dicas, Universi-
dade de Sa˜o Paulo, Brazil) showed evidence that peptides
similar to those released by the proteasome could keep a
biological activity, interfering with intracellular signaling,
protein/protein interactions or both, thereby acting as natural
regulators of signaling events. High-throughput peptidomics is
now being applied in different pathophysiological settings, and
soon these data will be correlated with different diseases.
Eventually, causal associations may be found, as it has been
suggested in the deposition of protein aggregates. Antici-
pating that, Ferro and colleagues are developing the tools to
transform these natural peptides into signaling or supramo-
lecular protein structure disruptors. Anjana Rao (Harvard
Medical School, USA) addressed the importance of hydro-
xymethylation of DNA in regulating gene expression and
myeloid tumorigenesis. Rao showed that the expression
of TET2, an enzyme that converts 5-methylcytosine to
5-hydroxymethylcytosine (5-hmC) in DNA, causes loss of
5-methylcytosine in parallel with an increased level of 5-hydro-
xymethylcytosine in genomic DNA. This activity is abolished
by mutations that impair the catalytic activity of the enzyme, as
well as by leukemia-associated mutations in residues that
have a role in catalysis. Also, she showed that the mutational
status of the TET2 locus correlated with the level of 5-hmC in
genomic DNA from patients with different myeloid malignan-
cies. Finally, Rao’s findings indicate that appropriate hydro-
xymethylation of DNA is critical for suppressing myeloid
tumorigenesis. Sankar Ghosh (Columbia University, USA)
presented some exciting results on the regulation of immune
and inflammatory responses by NF-kB. Using molecular,
biochemical and genetic in vivo strategies, Ghosh’s group was
able to show that different IkB isoforms exert specific
biological effects by the activation of different individual
members of the NF-kB family, culminating in the regulation
of different sets of genes during cell activation. Therefore
NF-kB has a central, evolutionarily conserved role in
coordinating immune responses, which control many basic
physiological processes and may be involved in a variety of
severe pathologies, including inflammatory and autoimmune
diseases. Carl Ware (La Jolla Institute for Allergy and
Immunology, USA) revealed a novel regulation of the
noncanonical (p100 and Rel B) NF-kB pathway, which
depends on the NF-kB-inducing kinase (NIK). In unstimulated
cells, NIK is targeted for proteasomal degradation by the
ubiquitin-NIK E3 ligase formed by TRAF2, TRAF3 and c-IAP
and, therefore, unavailable for NF-kB activation. Lympho-
toxin-b receptor (LTbR) stimulation disrupts the complex
TRAF2/TRAF3/c-IAP/NIK, recruiting TRAF2 and TRAF3 to
the receptor and targeting them for degradation. Once NIK is
released, it associates with IKKa and activates NF-kB.
Ca2þ Mobilization and Signaling
Patrick Hogan (La Jolla Institute for Allergy and Immunology,
USA) discussed the involvement of sensor protein STIM1
and the channel subunit ORAI1 on the regulation of Ca2þ
influx in mammalian T cells. To study STIM1-ORAI1 signaling
in vitro, Hogan’s group have expressed ORAI1 in yeast
Saccharomyces cerevisiae, and isolated sealed membrane
vesicles carrying ORAI1 from the Golgi compartment to the
plasma membrane. They showed by in vitro Ca2þ flux assays
that recombinant STIM1 opens wild-type ORAI1 channels, but
not channels assembled from the ORAI1 pore mutant E106Q
or the ORAI1 SCID mutant R91W. These experiments show
that the STIM1/ORAI1 interaction is sufficient to gate
recombinant human ORAI1 channels in the absence of other
proteins of the human ORAI1 channel complex. Studying
intracellular calcium alterations in neurodegenerative and
aging processes, Soraya Smaili (Universidade Federal de
Sa˜o Paulo, Brazil) showed compelling evidences that
amyloid-b (Ab) induces Ca2þ mobilization from the endo-
plasmic reticulum of rat astrocytes, probably through IP3
receptors, which, in turn, causes Bax translocation from the
cytosol to the mitochondria. The importance of this event to
the development of Alzheimer’s disease and other neuro-
degenerative and aging process was discussed.
Cell Cycle Control
Steve Reed (The Scripps Research Institute, La Jolla) is
dissecting the molecular mechanisms by which quiescent
cells reenter the cell cycle, and showed evidence for novel
roles of both Cdk2 and Cdc7 in this process. Cyclin E-Cdk2
promotes the accumulation of Cdc7 kinase, which in turn
phosphorylates Mcm2, one of the six MCM proteins found in
the pre-replication complex. Phosphorylation of Mcm2 is a
required step for its loading onto chromatin and assembly of
the pre-replication complex. Cyclin E is also involved in earlier
steps of the assembly of the pre-replication complex, as the
recruitment of the subunits of the origin recognition complex
(ORC) to DNA. Adriana Hemmerly (Universidade Federal do
Rio de Janeiro, Brazil) showed that ORC1 has a double role in
cell-cycle control. It does not only participate in the licensing of
DNA replication in the nucleus, but also functions as a
regulator of centriole reduplication, limiting its duplication to
once per cell cycle, thereby helping to maintain genome
integrity.
Signaling in Cell Death
A dazzling structural analysis of DD (‘death domain’)
complexes based on protein crystallography, electron micro-
scopy and biochemistry was presented by Hao Wu (Cornell
University, USA). Among other things, Wu showed attractive
images showing that Fas and FADD form an oligomeric
structure composed of a layer of five Fas DD associated with
another layer of five FADD DD, thereby placing the DED
domain of FADD in a proper way as to interact with the DED
domain of the caspase-8 forming a higher-magnitude
oligomer. Wu also showed that the mutations of Fas that
is associated with the autoimmune lymphoproliferative
syndrome mapped to the interface of these layers and
are detrimental to the death-inducing signaling complex
formation. The structure of IRAK-1/IRAK-4/MYD88 and its
implication to signaling transduction was also discussed
during her talk. Sharad Kumar (Centre for Cancer Biology,
Australia) talked about the cell death machinery during
Drosophila metamorphosis and pointed out that Dronc is
required for most developmental cell death but not for midgut
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cell death. Instead, most of the caspase activity in dying
midguts is due to decay. Importantly, inhibition of autophagy,
but not caspase activity, delay midgut cell death showing
for the first time an in vivo caspase-independent form of
PCD. Henning Walczak (Imperial College London, UK) put
forward a novel modified tandem affinity purification
procedure, which increased the specificity of immunoprecipi-
tation, to study the composition of the TNF-receptor signaling
complex (TNF-RSC). Walczak showed that two novel
proteins are recruited to the complex, HOIL-1 and HOIP.
The two associate to form a linear ubiquitin chain assembly
complex responsible for assembling linear head-to-tail ubi-
quitin chains. HOIL-1 recruitment to the TNF-RSC depends
on the E3 ligase activity of c-IAP-1/2 but not of TRAF2. Finally,
using knocking down strategies, he showed that HOIL-1 and
HOIP are important for proper TNF-induced NF-kB and
JNK activation and, therefore, crucial regulators of some
TNF-target genes.
Signaling in Cancer
The perspective of targeting signaling pathways in cancer was
addressed in different systems. Sergio Lira (Mount Sinai
School of Medicine, USA) revealed the first chemokine
receptor implicated in cancer. US28 is a constitutively active
viral chemokine receptor encoded by the HHV5 (CMV) that is
involved in b-catenin stabilization and upregulation of c-myc,
survivin and cyclin D1 expression. Transgenic mice expres-
sing US28 in intestinal epithelial cells develop colonic and
jejunal adenomas and carcinomas. Simultaneous expression
of CCL2 and US28 leads to increased frequency of tumors.
Work on the physiological roles of the prion protein (PrPc)
conducted by Vilma Martins and colleagues (Sa˜o Paulo
Branch of the Ludwig Institute for Cancer Research, Brazil)
has been suggesting that PrPc serves as a scaffolding
protein, organizing supramolecular complexes on the cell
surface of a variety of normal and tumor cells. PrPc seems
involved in survival, proliferation and differentiation of cells,
including neurons and glia cells. Dissection of PrPc com-
plexes led to the identification of a putative prion receptor,
STI1/Hop. Modulation of Hop/PrPc interaction in tumor cells
seems a promising strategy to control tumor growth, as shown
by preclinical data. Nigel Waterhouse (Peter MacCallum
Cancer Center, Australia) aims at sensitizing tumor cells to
cytotoxic lymphocytes. In his own previous work, Waterhouse
and colleagues showed that primary human NK cells induced
apoptosis of cells whose mitochondria were protected by
Bcl-2 in a Granzyme-B-dependent manner. Purified Gran-
zyme B could also trigger apoptosis of cells overexpressing
Bcl-2. However, the amount of Granzyme B needed to kill
these cells was one order of magnitude higher than the
amount necessary to kill cells expressing endogenous
levels of Bcl-2. Granzyme B triggers cell death through two
hierarchically dependent pathways: one which is Bcl-2
inhibitable, mitochondrial dependent and caspase indepen-
dent, and a second, which is mitochondrial independent and
caspase dependent. Granzyme B exerts a pressure for cells
to die and experimental data indicated that if following
Granzyme B exposure, Bcl-2 activity was inhibited by the
small molecule ABT-737, cell death would occur. However,
inhibition of Bcl-2 needs to take place within 16 h after
exposure to Granzyme B: a narrow window of opportunity. A
challenge for the future will be to translate this elegant concept
into therapy. Gerry Melino (MRC, England and Universita´ di
Roma Tor Vergata, Italy) presented data on a member of the
ubiquitin-specific protease (USP) family; USP47, a ligand but
not a substrate of b-Tcrp. Interestingly, both genetic and
siRNA-mediated knockdown of USP47 induced accumulation
of cdc25a, decreased cell survival and chemosensitized cells
to known chemotherapeutic drugs. Taken together, the data
suggest USP47 as a novel target for anticancer therapies. As
a physician-scientist, Carlos Gil (Instituto Nacional de Caˆncer,
Brazil) commented on the hurdles of translating promising
strategies, such as those presented in the meeting to the
patient’s bedside. Although it seems clear that this will be the
century of targeted therapies, we still know little about the
diseases we intend to treat. Facing the heterogeneity of
cancers at the molecular level, as pointed by Scott Lowe just in
the beginning of the meeting, there is simply no reason to
insist on a single treatment to different (molecular) diseases,
even if the pathologist diagnoses them all as the same
disease (at the cellular or tissue level).
Signaling in Inflammation and Innate Immunity
An intense and productive discussion on the detailed signaling
mechanisms in response to inflammation and infection was
engaged during the meeting. In an elegant series of imaging
and functional studies in whole eosinophils and purified
granules, Peter Weller (Harvard Medical School, USA)
detailed the signaling mechanisms that regulate the selectivity
of human eosinophil secretion. It is known that human
eosinophils contain within their granules multiple preformed
proteins, including over 30 cytokines and 4 distinctive cationic
proteins that may be rapidly mobilized on eosinophil stimula-
tion and contribute to eosinophil-mediated inflammation and
immunomodulation. However, the mechanisms that govern
the selective release of proteins from within the granules are
not well appreciated. Weller showed that granules of human
eosinophils express membrane receptors for cytokines/
chemokines, and that these receptors function by triggering
signaling pathways within granules to elicit selective secretion
of their components. In addition, Weller went on to show that
eosinophil granules might function as autonomous organelles
outside of eosinophils as ligand-responsive, secretion-
competent structures. Mauro Teixeira (Universidade Federal
de Minas Gerais, Brazil) argued about the importance of the
selective and timely induction of apoptosis of granulocytes for
the resolution of inflammation and showed that cyclic AMP is
important in resolving inflammation by cell-specific mechan-
isms. Although the actions of cAMP in eosinophilic inflamma-
tory resolution are dependent on PKA and target a PI3K/
Akt-dependent NF-kB survival pathway, cAMP effects on
neutrophilic inflammation resolution occur through caspase-
dependent apoptosis of inflammatory cells by targeting an
NF-kB-independent PKA/PI3K/Akt-dependent survival path-
way. Rafael Linden (Universidade Federal do Rio de Janeiro,
Brazil) addressed the role of the prion protein PrPc in the
control of phagocytic and inflammatory responses. Macro-
phages from PrPc gene knockout mice have higher rates of
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phagocytosis than wild-type macrophages. Moreover, the
inflammatory responses involving activation of either TLR2 or
TLR4 are tuned by PrPc. Conversely, inflammation leads to
induction of PrPc. The existence of these regulatory loops
anticipates the involvement of PrPc in autoimmunity, boosting
(even more) the interest in the mad cow disease protein. Elvira
Saraiva (Universidade Federal do Rio de Janeiro, Brazil)
talked about the control of infection by NETosis, a recently
described form of cell death that occurs in neutrophils in
response to certain parasites. NETosis is characterized by the
release of neutrophil extracellular traps (NETs), which is
formed by a fibrous network composed of pieces of DNA,
histones and granule proteins, such as elastases. Saraiva
presented startling pictures and quantitative data showing that
Leishmania and other parasites induce the release of and are
killed by NETs. Interestingly, disruption of NETs by DNase
treatment or by anti-histone antibodies increased parasite
survival. Meshes composed of DNA and elastase were
evidenced in biopsies of human cutaneous leishmaniasis.
Also working on Leishmania, Marcela Lopes (Universidade
Federal do Rio de Janeiro, Brazil) showed that L. major
infection of B6 mice expressing v-FLIP (a viral inhibitor of
caspase-8) in T cells resulted in increased T-cell survival and
IL-4 production compared with wild-type mice. Despite the
intense Th2 response, which is normally harmful to the
mice, B6/v-FLIP mice developed strong resistance to
L. major infection associated with expansion of myeloid-
derived suppressor cells capable of producing nitric oxide.
Signaling lymphocyte activation molecule (SLAM), a
glycoprotein expressed on activated lymphocytes and antigen-
presenting cells, has been shown to function as co-stimulatory
molecules through their homophilic or heterophilic interac-
tions. Cox Terhorst (Harvard Medical School, USA) expanded
the role of SLAM family of receptors to innate immunity by
showing that these receptors function as bacterial sensors
capable of discriminating Gram-positive from Gram-negative
bacteria thereby initiating innate immune signaling. The nod-
like receptor (NLR) family constitutes a group of cytoplasmic
sensors of pathogen-associated molecular patterns, which
trigger signaling cascades that culminate with NF-kB or
caspase-1 activation. Dario Zamboni (Faculdade de Medicina
de Ribeira˜o Preto, Universidade de Sa˜o Paulo, Brazil)
presented data that unequivocally show that Coxiella infection
does not trigger caspase-1 activation and consequently may
somehow avoid recognition by NLRs. Moreover, by perform-
ing co-infections with Legionella, Zamboni went on to show
that Coxiella is capable of inhibiting caspase-1 activation by
Legionella-infected cells, giving support to the hypothesis that
Coxiella is in fact able to subvert activation of caspase-1 and
the inflammasome, possibly aiming to establish a replicative
vacuole that enables intracellular microbial multiplication.
As to malaria pathogenesis, the signaling determinants of
malaria-induced cytokine storm that leads to fever and sepsis
are poorly understood. Douglas Golembock (University of
Massachusetts Medical School, USA) presented novel find-
ings revealing the importance of a synergistic effect of
P. falciparum DNA and hemozoin as the cause of fever in
malaria. Golembock clearly showed that although hemozoin
does not directly triggers TLR9 activation, it is crucial in the
intracellular trafficking of P. falciparum DNA to trigger TLR9/
MyD88-dependent and -independent signaling pathways for
cytokine production. The TLR9/MyD88 independent activa-
tion was shown to occur through NALP-3 and ASC. These
findings may open new avenues for the therapeutic interven-
tion in malaria. Miguel Soares (Instituto Gulbenkian de
Cieˆncia, Portugal) discussed novel molecular aspects
involved in host tolerance to infection. Soares presented solid
evidence that free heme is released during severe infection
including malaria and polymicrobial sepsis and functions as a
common pathological mechanism that impairs host tolerance
to infection, leading to cell death and tissue damage. He also
discussed the role of stress-responsive genes, in particular
the key role played by HO-1, in limiting the deleterious effects
of free heme preventing tissue damage and promoting host
survival. Ricardo Gazzinelli (Universidade Federal de Minas
Gerais, Brazil) revealed a critical role for UNC93B1, a multiple
membrane-spanning endoplasmic reticulum protein, on the
control of Toxoplasma infection. Interestingly, Gazzinelli
presented convincing findings that although UNC93B1-
deficient mice mount a typical proinflammatory response
with abundant IFN-g, the animals were unable to control
parasite replication. Therefore, UNC93B1 seems to control
Toxoplasma infection through mechanisms independent of
TLR function and dependent of the trafficking of intracellular
parasite-containing vesicles. Novel survival strategies and
host/defense evasion mechanisms triggered by Brucella spp.
and M. tuberculosis (Mtb) were also discussed. The innate
immune recognition and signaling triggered by Brucella spp.
infection are particularly very poorly understood. Se´rgio Costa
Oliveira (Universidade Federal de Minas Gerais, Brazil)
provided a solid body of evidences to conclude that B. abortus
and its DNA has the ability to induce type I IFN synthesis,
independently of TLR2, TLR4, TLR9 or TRIF, but dependent
on MyD88 and IRF-3. Interestingly, splenocytes from
IFN-abR-deficient mice showed a significant increase in
IFN-g and NO level when cultured with B. abortus and a lower
apoptotic index when compared with wild-type mice, suggest-
ing that the B. abortus-mediated production of type I IFN is
one of the host/defense evasion mechanisms triggered by this
pathogen. By using a combination of genome-wide microarray
and immunohistological analysis of caseous human TB
granulomas, David Russell (Cornell University, USA) pro-
vided biochemical and molecular evidence that the transition
of the human tuberculosis granuloma to caseation is
promoted by pathogen-mediated deregulation of lipid
metabolism leading to lipid accumulation and foamy macro-
phage formation. This mechanism involves TLR2 and
MARCO-dependent signaling and implicates the innate
immune system in disease progression. Jean Pieters
(University of Basel, Switzerland) discussed the mechanisms
involved in the regulation of Mtb and T-cell survival through
coronin-1, a leukocyte-specific regulator of Ca2þ -dependent
signaling. Pieters showed that on infection, coronin-1 is
actively recruited to mycobacterial phagosomes. Although
coronin-1 is dispensable for all F-actin-mediated functions,
including phagocytosis, it is required for the activation of
the Ca2þ -dependent phosphatase calcineurin processes in
macrophages, revealing a function for calcineurin in the
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Signaling in Adaptive Immunity
Th17 cells are considered the most recent double-edged
sword of the immune system. Vijay Kuchroo (Harvard Medical
School, USA) and Dan Littman (HHMI and New York
University, USA) gave remarkable overviews about the
molecular mechanisms that control Th17 cell differentiation.
On the basis of expression profiling and systems biology
approaches, Kuchroo showed that the expression of orphan
nuclear receptor RORgT, a key transcription factor regulating
Th17 cell development described by Littman’s group, is
initiated early on TGF-b1 and IL-6 stimulation. This induction
phase is followed by upregulation in the IL-21 expression, a
key factor for Th17 cell amplification. Finally, IL-23R expres-
sion and signaling lead to Th17 phenotype stabilization.
By using chromatin immunoprecipitation followed by high-
throughput sequencing (ChIP-Seq), Littman showed that
other nuclear factors, for example STAT3 and IRF-4,
collaborate with RORgt to regulate transcription and the
generation of IL-17-producing cells. Beneficial and pathologi-
cal roles of Th17 cells were also presented in this section.
Illustrated by wonderful scanning electron microscopy
pictures, Littman showed that the accumulation of Th17 cells
in murine intestinal mucosa colonized by segmented filamen-
tous bacteria protects mice from overgrowth of pathogenic
intestinal bacteria. Kuchroo highlighted another feature of
Th17 by showing their cooperation with B cells leading to
B-cell proliferation, antibodies class switch to IgG1, IgG2a and
IgG3 isotypes, and germinal center formation. The pathologic
role of Th17 cells was also shown by Kuchroo where in vitro
derived Th17 cells from naive TCR transgenic mice with
specificity for myelin antigens induce a more severe EAE
when compared with Th1 cells of the same specificity.
Alexander Rudensky (HHMI and University of Washington,
USA) discussed the features of regulatory T cells (Tregs)
responsible for the immune homeostasis and for the
suppressing overexuberant immune responses. He focused
on the role of conserved non-coding DNA sequence (CNS)
elements at the Foxp3 locus for the determination of Treg fate.
Rudensky’s group is addressing the particular requirement of
distinct Foxp3 CNS elements for the control of thymus or
peripheral Treg subpopulations composition, size and main-
tenance. Focusing on CD8þ T cells, Mauricio Rodrigues
(Universidade Federal de Sa˜o Paulo, Brazil) proposed an
efficient vaccine strategy for experimental Chagas’ disease by
using a replication-deficient human adenovirus type 5
expressing the T. cruzi immunodominant CD8 epitopes.
Specific CD8þ T cells expanded following adenoviral
vaccination, acquiring a typical T-effector phenotype and
cytotoxic activity. Moreover, these cells drastically down-
modulated the expression of the apoptotic signaling receptor
CD95 (Fas) induced by pathogen infection. Thus, in addition
to the induction of effector immune cells before the pathogen
encounter, the adenoviral vaccination seem to reprogram
pathogen-specific CD8þ T cells expanded after an infectious
challenge. In an enthusiastic talk, Hilde Cheroutre (La Jolla
Institute for Allergy and Immunology, USA) showed that the
gut environment selects for the ‘fittest’ immune cells
through TL-mediated signals from epithelial cells. TL induces
apoptosis in activated CD8ab T cells, but it is inhibited by the
expression of activation-induced CD8aa in these cells.
Interestingly, TGF-b, abundant in the gut, is required for the
conversion of CD4 T cells into CD8aaCD4 T cells that, in their
turn, is capable to acquire a CD8 cytotoxic phenotype. Mitchell
Kronenberg (La Jolla Institute for Allergy and Immunology,
USA) used different experimental systems to investigate the
role of TNF receptor family HVEM in T-cell responses. Using a
model of colitis induced by transfer of CD4þCD45RBhigh
T cells into rag- deficient mice, Kronenberg and colleagues
verified that the absence of HVEM in radio-resistant cells,
probably the intestinal epithelial cells, resulted in accelerated
intestinal inflammation. Administration of agonistic anti-BTLA
antibodies prevented the accelerated colitis, highlighting the
importance of the HVEM-BTLA interaction to the control of
intestinal inflammation. An apparent opposing effect of HVEM
was seen in mice infected with Citrobacter rodentium, since
HVEM deficiency resulted in impaired bacterial clearance and
increased susceptibility to infection.
Closing Remarks
The meeting was enthusiastically wrapped up by Douglas
Green (St. Jude Children’s Research Hospital, USA), who
pointed out evolutionary aspects as well as the importance of
mitochondrial events in the control of life and death of
vertebrate cells. He reviewed and discussed the fundamental
mechanisms controlling the mitochondrial outer membrane
permeabilization (MOMP), the critical step for effector
caspase activation and apoptosis, and also for caspase-
independent cell death. MOMP is controlled by pro- and
antiapoptotic members of the Bcl-2 family. Bax and Bak are
the proapoptotic effectors and Bcl-2, Bcl-xL and MCL-1 are
the antiapoptotic proteins that regulate the so-called BH3-only
members of this family (Bid, Bim, Bad, Noxa, Puma and so
on). Green argued in favor of the existence of both the
‘neutralization’ and the ‘direct activator/derepressor’ models
of function of Bcl-2 family proteins and drew attention to the
fact that each one leads to different outcome, with particular
implications for the development of therapeutic interventions.
Last, but not least, he revisited the concept of ‘commitment
point’ he proposed some years ago, reemphasizing the
consequence of MOMP to mitochondrial dynamics and
bioenergetics as a mechanism to ensure death of a cell even
in the absence of caspase activation.
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